CD177 and COVID-19: Elevated concentrations of CD177 were recently identified by transcriptomics in the peripheral blood (32) and by proteomics in BAL cells (33) of patients with COVID-19 with mild and severe disease, which supports our data suggesting an upregulation of CD177 in the lung culture–positive decedents.